April 7, 2026
Mike Sharma named 2026 Hnatyshyn lecturer
Mike Sharma, PHRI senior scientist, has been selected to deliver the prestigious 2026 Hnatyshyn Lecture at the upcoming Canadian Stroke Congress, in...
Read More
March 21, 2026
ENRICH-AF: Finding a safer way to reduce stroke risk post brain hemorrhage in atrial fibrillation
For people living with atrial fibrillation, the risk of stroke is always present. Doctors often prescribe anticoagulant medications to lower...
Read More
March 20, 2026
LEAST: Testing a diabetes drug to support recovery after severe stroke
PHRI researchers are studying whether a widely used type 2 diabetes medication could help improve recovery after large vessel occlusion...
Read More
March 19, 2026
PROSPECT: Understanding cognitive and functional recovery after stroke
Stroke is a major contributor to death and disability globally, and its burden will increase dramatically with ageing populations. While advances...
Read More
March 18, 2026
Clot‑busting meds + DOACs post stroke: DO-IT or not?
When someone has an ischemic stroke (a stroke caused by a blood clot), intravenous thrombolysis (IVT), a clot‑busting drug, can...
Read More
March 17, 2026
Could targeting inflammation after brain hemorrhage safely reduce stroke and heart attack risk?
People who experience an intracerebral hemorrhage (ICH) face a high risk of stroke, blood clots, and long‑term disability. Current treatments often do not reduce...
Read More